Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,598 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting vectors for cancer gene therapy.
Nakamura K, Kato K, Tanaka T, Hamada H. Nakamura K, et al. Front Biosci (Elite Ed). 2009 Jun 1;1:332-40. Front Biosci (Elite Ed). 2009. PMID: 19482650 Review.
Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope.
Ikeda M, Yamaguchi M, Kato K, Nakamura K, Shiina S, Ichikawa-Ando T, Misaka H, Myojo K, Nakamura K, Sugimoto Y, Hamada H. Ikeda M, et al. Biochem Biophys Res Commun. 2015 Mar 20;458(4):877-82. doi: 10.1016/j.bbrc.2015.02.051. Epub 2015 Feb 19. Biochem Biophys Res Commun. 2015. PMID: 25701778
Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens.
Uchida H, Hamada H, Nakano K, Kwon H, Tahara H, Cohen JB, Glorioso JC. Uchida H, et al. Curr Cancer Drug Targets. 2018;18(2):162-170. doi: 10.2174/1568009617666170206105855. Curr Cancer Drug Targets. 2018. PMID: 28176649 Review.
Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts.
Takenouchi M, Hirai S, Sakuragi N, Yagita H, Hamada H, Kato K. Takenouchi M, et al. Clin Cancer Res. 2011 May 1;17(9):2819-29. doi: 10.1158/1078-0432.CCR-10-2986. Epub 2011 Feb 28. Clin Cancer Res. 2011. PMID: 21357681
EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
Kawashima R, Abei M, Fukuda K, Nakamura K, Murata T, Wakayama M, Seo E, Hasegawa N, Mizuguchi H, Obata Y, Hyodo I, Hamada H, Yokoyama KK. Kawashima R, et al. Int J Cancer. 2011 Sep 1;129(5):1244-53. doi: 10.1002/ijc.25758. Epub 2011 Jan 6. Int J Cancer. 2011. PMID: 21710497
A database of recombinant viruses and recombinant viral vectors available from the RIKEN DNA bank.
Ugai H, Murata T, Nagamura Y, Ugawa Y, Suzuki E, Nakata H, Kujime Y, Inamoto S, Hirose M, Inabe K, Terashima M, Yamasaki T, Liu B, Nakade K, Pan J, Kimura M, Saito I, Hamada H, Obata Y, Yokoyama KK. Ugai H, et al. J Gene Med. 2005 Sep;7(9):1148-57. doi: 10.1002/jgm.786. J Gene Med. 2005. PMID: 15945121
Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts.
Ichiba M, Shimomura T, Murai R, Hashiguchi K, Saeki T, Yoshida Y, Kanbe T, Tanabe N, Tsuchiya H, Miura N, Tajima F, Kurimasa A, Hamada H, Shiota G. Ichiba M, et al. Biochem Biophys Res Commun. 2005 Sep 30;335(3):723-9. doi: 10.1016/j.bbrc.2005.07.127. Biochem Biophys Res Commun. 2005. PMID: 16087157
Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration.
Seo E, Abei M, Wakayama M, Fukuda K, Ugai H, Murata T, Todoroki T, Matsuzaki Y, Tanaka N, Hamada H, Yokoyama KK. Seo E, et al. Cancer Res. 2005 Jan 15;65(2):546-52. Cancer Res. 2005. PMID: 15695398
1,598 results
Jump to page
Feedback